Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)

NCT01084551 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

284

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Restless Legs Syndrome

Interventions

DRUG: SPM 962
DRUG: SPM 962
DRUG: Placebo of SPM 962

Sponsor

Otsuka Pharmaceutical Co., Ltd.